Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae. Tam VH, Merlau PR, Hudson CS, Kline EG, et al. J Antimicrob Chemother 2022;77:3130-3137.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tam VH, Merlau PR, Hudson CS, Kline EG, et al. Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother 2022;77:3130-3137.
PMID: 36031868